NCT06305390View on ClinicalTrials.gov

Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.

RecruitingOBSERVATIONAL

Enrollment

167

Participants

Timeline

Start Date

December 4, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2026

Conditions

Clinical Suspicion of Prostate Cancer

Interventions

DIAGNOSTIC_TEST

PET/MRI

18F-PSMA PET/MRI

Trial Locations (1)

20132

RECRUITING

U.O. of Nuclear Medicine, ,Ospedale San Raffaele, Milan

All Listed Sponsors

lead

IRCCS San Raffaele

OTHER